Old challenges and new opportunities in the clinical management of heterozygous familial hypercholesterolemia (HeFH): The promises of PCSK9 inhibitors
2017 ◽
Vol 256
◽
pp. 134-145
◽
2017 ◽
Vol 27
(1)
◽
pp. e4-e5
2018 ◽
Vol 14
(5)
◽
pp. 962-970
◽
2016 ◽
Vol 10
(5)
◽
pp. 1278-1279
◽
1998 ◽
Vol 31
(2)
◽
pp. 55A